SARS-CoV-2 Trimeric Spike Indian B.1.617.2
P-353-100
Datasheet as| Name | SARS-CoV-2 Trimeric Spike Indian B.1.617.2 |
| Description | Protein contains amino acids 14-1211 and following mutations: T19R, G142D, E156G, del_F157-R158 L452R, T478K, D614G, P681R. Plus two extra amino acids (AS) in N-terminus, trimerization domain and His-6 tag at C-terminus, GS linker between protein and trimerization domain and GSG linker between trimerization domain and His-tag. Furin cleavage (RRAR) site between Spike S1 and S2 is mutated (GSAS). |
| Uniprot ID |
P0DTC2
|
| Source | Human |
| MW | 410.37 kDa |
| Host |
CHO-based cell line (expressed by QMCF Technology)
|
| Purification |
Purified by Ni-affinity chromatography and gel-filtration from serum-free CHO growth media, sterile filtrated
|
| Purity | >95% |
| Concentration | 1 mg/ml |
| Buffer |
PBS pH 7.4
|
| Endotoxine | NA |
| QC |
SDS-PAGE,
analytical SEC, Octet binding
|
| Shipping | Shipped on dry ice. |
| Storage |
Store
at -20 °C to -70 °C long term. Avoid multiple freeze-thaw cycles.
|
Buy now
€750 / 100µg
€1450 / 500µg
€1950 / 1000µg
Figure 1.
Simply Blue stained
SDS-PAGE analysis of
SARS-CoV-2 Trimeric Spike Indian B.1.617.2
. 4-12%
gradient gel is used for analysis. Lane 1. 0.8 µg
SARS-CoV-2 Trimeric Spike Indian B.1.617.2
(-DTT) Lane 2. Protein marker (Smobio) Lane 3. 0.8 µg
SARS-CoV-2 Trimeric Spike Indian B.1.617.2
(+DTT)
